Novo Nordisk’s GLP-1 agonist Ozempic has shown efficacy in yet another indication, achieving a 24% reduction in kidney disease-related events in people with type 2 diabetes and chronic kidney disease ...
The Catholic share of the population in several Latin American countries has shrunk over the last 10 years, while a growing percentage of Latin American adults are religiously unaffiliated. Fresh data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback